Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone after revascularization for acute large vessel occlusion stroke
ChiCTR2100051729Phase 4Recruiting
- Sponsor
- Xinqiao Hospital
- Start
- Feb 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in ischemic stroke comparing Placebo group with Methylprednisolone group (2 arms). Primary endpoints: Modified Rankin Scale score at 90 days, Death at 90 days and 2 more. Started Feb 2022; status: recruiting.
02
Drugs
methylprednisolone
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR2100051729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100051729.